Literature DB >> 28804821

D-Dimer Testing: Laboratory Aspects and Current Issues.

Jecko Thachil1, Giuseppe Lippi2, Emmanuel J Favaloro3.   

Abstract

D-dimer has become one of the commonly requested coagulation tests, especially in the venous thromboembolism rule out setting. Appropriate D-dimer testing has significantly decreased the number of radiological investigations in this clinical scenario. D-dimer testing also plays an important role in the diagnostic process of the systemic coagulation disorders, especially disseminated intravascular coagulation in conjunction with other coagulation tests. However, widespread D-dimer testing without good understanding of the technical issues related to the test has recently caused some concerns. This review aims to address the basic physiology of D-dimer formation, the different methods available for its routine assessment, the current problems that both clinicians and laboratory scientists face with this test, and the important need for harmonization of commercial immunoassays.

Entities:  

Keywords:  D-dimer testing; Disseminated intravascular coagulation; Limitations; Venous thromboembolism

Mesh:

Substances:

Year:  2017        PMID: 28804821     DOI: 10.1007/978-1-4939-7196-1_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  10 in total

1.  Mass spectrometry-based molecular mapping of native FXIIIa cross-links in insoluble fibrin clots.

Authors:  Lauren R Schmitt; Rachel Henderson; Alexander Barrett; Zsuzsanna Darula; Aaron Issaian; Angelo D'Alessandro; Nathan Clendenen; Kirk C Hansen
Journal:  J Biol Chem       Date:  2019-04-26       Impact factor: 5.157

2.  Pediatric Critical Illness Score, Clinical Characteristics and Comprehensive Treatment of Children with Severe Mycoplasma Pneumoniae Pneumonia.

Authors:  Chengchao Fang; Yueyan Mao; Mingfen Jiang; Wei Yin
Journal:  Front Surg       Date:  2022-05-25

3.  Predictive Value of C-reactive Protein, Lactate Dehydrogenase, Ferritin and D-dimer Levels in Diagnosing COVID-19 Patients: a Retrospective Study.

Authors:  Ahmed N Kaftan; Majid K Hussain; Abdulhussein A Algenabi; Farah H Naser; Muslim A Enaya
Journal:  Acta Inform Med       Date:  2021-03

4.  Predictability of CRP and D-Dimer levels for in-hospital outcomes and mortality of COVID-19.

Authors:  Waqas Ullah; Nishanth Thalambedu; Shujaul Haq; Rehan Saeed; Shristi Khanal; Shafaq Tariq; Sohaib Roomi; John Madara; Margot Boigon; Donald C Haas; David L Fischman
Journal:  J Community Hosp Intern Med Perspect       Date:  2020-09-03

Review 5.  Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes.

Authors:  Corlia Grobler; Siphosethu C Maphumulo; L Mireille Grobbelaar; Jhade C Bredenkamp; Gert J Laubscher; Petrus J Lourens; Janami Steenkamp; Douglas B Kell; Etheresia Pretorius
Journal:  Int J Mol Sci       Date:  2020-07-21       Impact factor: 5.923

6.  Peripherally inserted central venous catheter in upper extremities leads to an increase in D-dimer and deep vein thrombosis in lower extremities.

Authors:  Wanli Liu; Lianxiang He; Wenjing Zeng; Liqing Yue; Jie Wei; Shuangshuang Zeng; Xiang Wang; Zhicheng Gong
Journal:  Thromb J       Date:  2021-04-09

7.  Age-Adjusted D-Dimer in the Prediction of Pulmonary Embolism: Systematic Review and Meta-analysis.

Authors:  Kenneth Iwuji; Hasan Almekdash; Kenneth M Nugent; Ebtesam Islam; Briget Hyde; Jonathan Kopel; Adaugo Opiegbe; Duke Appiah
Journal:  J Prim Care Community Health       Date:  2021 Jan-Dec

8.  Standardization of D-dimer reporting in the COVID-19 era.

Authors:  Litao Zhang; Zhenlu Zhang
Journal:  Res Pract Thromb Haemost       Date:  2022-09-20

Review 9.  Lessons learnt from COVID-19 coagulopathy.

Authors:  Jecko Thachil
Journal:  EJHaem       Date:  2021-05-17

10.  Opportunistic Diagnosis of Extensive Pulmonary Embolus Following "COVID-19 Blood Battery" in Very Frail Older Patients.

Authors:  M M C O'Brien; J M McLoughlin; E C Mulkerrin
Journal:  J Nutr Health Aging       Date:  2020       Impact factor: 4.075

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.